CYTK vs INTC · rev $28.6M vs rev $29.70B
Cytokinetics Inc (CYTK) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
CYTK currently screens at market cap $4.05B. INTC currently screens at market cap $498.43B.
Not investment advice. Open the CYTK and INTC stock pages for the full models.
Not investment advice.